{"url_path":"/sec/dnli/8-k/2026-06-04/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1714899/0001714899-26-000074-index.html","accession_number":"0001714899-26-000074","cik":"0001714899","ticker":"DNLI","issuer_name":"Denali Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1714899/0001714899-26-000074-index.html","primary_entity_key":"0001714899","primary_entity_name":"Denali Therapeutics Inc."},"word_count":69,"has_tables":true,"body_markdown":"Item 9.01    Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.Description\n\n104Cover Page Interactive Data File (formatted as Inline XBRL)\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDENALI THERAPEUTICS INC.\n\nDate:June 3, 2026By:\n/s/ Alexander O. Schuth\n\nAlexander O. Schuth, M.D.\n\nChief Operating and Financial Officer"}